Kronos Bio Inc
NASDAQ:KRON

Watchlist Manager
Kronos Bio Inc Logo
Kronos Bio Inc
NASDAQ:KRON
Watchlist
Price: 0.88 USD 1.49% Market Closed
Market Cap: 53.7m USD

During the last 3 months Kronos Bio Inc insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Jun 5, 2025 by Knobelman Deborah , who sold 21.6k USD worth of KRON shares.

Last Transactions:
Knobelman Deborah
$-21.6k
Bischofberger Norbert W
$+255k
Bischofberger Norbert W
$+478.8k
Bischofberger Norbert W
$+1.1m
Bischofberger Norbert W
$+814.6k
Bischofberger Norbert W
$+1.2m
Olek Elizabeth A
$-7.8k
Lin Charles Y
$-12.7k
Frisbee Allison
$-12.8k
Dinsmore Christopher
$-8.7k
Dimartino Jorge
$-14.2k
Kosacz Barbara
$-12.6k
Dinsmore Christopher
$-13.1k
Dimartino Jorge
$-22.7k
Bischofberger Norbert W
$+106.2k
Bischofberger Norbert W
$+261.5k
Bischofberger Norbert W
$+1.1m
Al-Wakeel Yasir B.
$-16.9k
Dimartino Jorge
$-19k
Dinsmore Christopher
$-11.6k
Dinsmore Christopher
$-10.9k
Dimartino Jorge
$-17.6k
Al-Wakeel Yasir B.
$-15.7k
Dimartino Jorge
$-33.7k
Dinsmore Christopher
$-16.5k
Bischofberger Norbert W
$+1.1m
Bischofberger Norbert W
$+768k
Bischofberger Norbert W
$+348.5k
Dimartino Jorge
$-199.7k
Dinsmore Christopher
$-138.6k
Bischofberger Norbert W
$+173.5k
De Backer Marianne
$+13.3k
View All Transactions

During the last 3 months Kronos Bio Inc insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Jun 5, 2025 by Knobelman Deborah , who sold 21.6k USD worth of KRON shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
21.6k USD
1
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Kronos Bio Inc
Insider Trading Chart

Kronos Bio Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Kronos Bio Inc
Last Insider Transactions

Global
Insiders Monitor

Kronos Bio Inc
Glance View

Market Cap
53.7m USD
Industry
Biotechnology

Kronos Bio, Inc. is a clinical-stage biopharmaceutical, engages in the provision of discovery and development of novel cancer therapeutics products. The company is headquartered in San Mateo, California and currently employs 96 full-time employees. The company went IPO on 2020-10-09. The firm is focused on the discovery and development of cancer therapeutics designed to target dysregulated transcription. Its product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks (TRNs) that drive their oncogenic activity. Its lead product candidate, entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase (SYK) inhibitor that is being developed for the treatment of acute myeloid leukemia (AML). Its second product candidate, KB-0742, is generated from its product engine’s small molecule microarray (SMM) platform. KB-0742 is designed to be an orally bioavailable inhibitor of CDK9 with a differentiated selectivity profile. Its KB-0742 is in advanced solid tumors with MYC genomic copy number gain (amplification).

KRON Intrinsic Value
1.59 USD
Undervaluation 45%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top